MARX Biotech Co., Ltd. (TPEX:7731)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
6.03
-0.02 (-0.33%)
Apr 24, 2025, 1:38 PM CST

MARX Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
74.67152.8327.730.18
Short-Term Investments
3.5---
Cash & Short-Term Investments
78.17152.8327.730.18
Cash Growth
-48.85%451.08%15479.78%-
Accounts Receivable
120.0298.4254.95-
Other Receivables
3.924.62--
Receivables
123.94103.0454.95-
Inventory
164.317012-
Prepaid Expenses
35.9313.980.83-
Other Current Assets
4.953.190.56-
Total Current Assets
407.3343.0496.070.18
Property, Plant & Equipment
217.194.264.73-
Long-Term Investments
---13.5
Goodwill
-5.37--
Other Intangible Assets
91.6130.1--
Long-Term Deferred Tax Assets
6.564.921.940.09
Other Long-Term Assets
8.547.150.450.03
Total Assets
731.2394.85103.1913.8
Accounts Payable
88.8823.725.26-
Accrued Expenses
-39.7712.980.5
Short-Term Debt
98-10-
Current Portion of Long-Term Debt
5.27---
Current Portion of Leases
3.91.262.97-
Current Income Taxes Payable
--3.41-
Current Unearned Revenue
40.2625.082.28-
Other Current Liabilities
72.1211.24.60.16
Total Current Liabilities
308.43101.0441.50.66
Long-Term Debt
165.04---
Long-Term Leases
5.110.620.87-
Long-Term Deferred Tax Liabilities
1.380.20.08-
Total Liabilities
479.95101.8642.450.66
Common Stock
126.5124.5140.88.05
Additional Paid-In Capital
220.48186.0317.983.21
Retained Earnings
-95.73-17.551.951.89
Shareholders' Equity
251.25292.9960.7313.14
Total Liabilities & Equity
731.2394.85103.1913.8
Total Debt
277.321.8813.84-
Net Cash (Debt)
-199.15150.9413.890.18
Net Cash Growth
-986.39%7705.62%-
Net Cash Per Share
-0.400.360.040.01
Filing Date Shares Outstanding
498.92498.06163.2132.18
Total Common Shares Outstanding
498.92498.06163.2132.18
Working Capital
98.87242.0154.57-0.48
Book Value Per Share
0.500.590.370.41
Tangible Book Value
159.64257.5260.7313.14
Tangible Book Value Per Share
0.320.520.370.41
Machinery
-2.71.03-
Construction In Progress
-00.02-
Leasehold Improvements
-1.10.44-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.